# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4482797 | B | Inhibition of MOCR-fused ASH1L SET-BAH ( 2069 to 2833 amino acids) (unknown origin) expressed as in Escherichia coli BL21 (DE3) T1R cells using SAM and chicken mono/dinucleosomes incubated for 1 hr by scintillation counting assay | Homo sapiens | 312 | assay format | Patent Bioactivity Data | ||
2. | ALA4482799 | F | Cytotoxicity in MLL-AF9 transformed mouse MA9 cells assessed as reduction in cell viability incubated for 12 days with fresh compound replacement for every 4 days by MTT assay | Mus musculus | 2 | cell-based format | Patent Bioactivity Data | ||
3. | ALA4482800 | A | Cytotoxicity in Hoxa9/Meis1 transformed mouse HM2 cells assessed as reduction in cell viability incubated for 12 days with fresh compound replacement for every 4 days by MTT assay | Mus musculus | 2 | cell-based format | Patent Bioactivity Data | ||
4. | ALA4482801 | F | Cytotoxicity in human MV4-11 cells assessed as reduction in cell viability incubated for 12 days with fresh compound replacement for every 4 days by MTT assay | Homo sapiens | 3 | cell-based format | Patent Bioactivity Data | ||
5. | ALA4482802 | F | Cytotoxicity in human MOLM13 cells assessed as reduction in cell viability incubated for 12 days with fresh compound replacement for every 4 days by MTT assay | Homo sapiens | 3 | cell-based format | Patent Bioactivity Data | ||
6. | ALA4482807 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX7 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
7. | ALA4482808 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX9 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
8. | ALA4482809 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of HOX10 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
9. | ALA4482810 | B | Inhibition of ASH1L in MLL-AF9 transformed mouse MA9 cells assessed as downregulation of Meis1 gene expression at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
10. | ALA4482811 | A | Effect on HOX7 gene expression in Hoxa9/Meis1 transformed mouse HM2 cells at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
11. | ALA4482812 | A | Effect on HOX9 gene expression in Hoxa9/Meis1 transformed mouse HM2 cells at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
12. | ALA4482813 | A | Effect on HOX10 gene expression in Hoxa9/Meis1 transformed mouse HM2 cells at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data | ||
13. | ALA4482814 | A | Effect on Meis1 gene expression in Hoxa9/Meis1 transformed mouse HM2 cells at 6 to 12 uM by quantitative RT-PCR analysis | Mus musculus | 2 | assay format | Patent Bioactivity Data |